Firebrick Pharma Pty Ltd

Status: Registered
Australian Company Number: 157765896
Australian Business Number: 64157765896
Registration date: Thu, 12th Apr 2012
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Firebrick Pharma Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2012-04-12 and was issued with the 157765896 ACN. Its Australian Business Number is 64157765896. Since 2021-03-04, the company is headquartered in VIC, post code 3000. The previous headquarters were located in VIC 3363 (from 2019-01-12 to 2021-03-04), VIC 3363 (from 2015-06-30 to 2019-01-12), and VIC 3754 (from 2014-08-20 to 2015-06-30). Firebrick Pharma Pty Ltd was registered for the GST on 2012-04-12. Firebrick Pharma Pty Ltd has been using the Firebrick Pharma trading name since 2012-04-12 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2021-12-16.

Details for ABN 64157765896

Type: Australian Public Company

ABN Status

Status From To
Active Thu, 12th Apr 2012 current

Main Name

Name From To
Firebrick Pharma Limited Thu, 15th Oct 2020 current
Firebrick Pharma Pty Ltd Thu, 12th Apr 2012 Thu, 15th Oct 2020

Trading Names

Name From To
Firebrick Pharma Thu, 12th Apr 2012 current

Main Location

Location From To
VIC 3000 Thu, 4th Mar 2021 current
VIC 3363 Sat, 12th Jan 2019 Thu, 4th Mar 2021
VIC 3363 Tue, 30th Jun 2015 Sat, 12th Jan 2019
VIC 3754 Wed, 20th Aug 2014 Tue, 30th Jun 2015
VIC 3754 Thu, 12th Apr 2012 Wed, 20th Aug 2014

Goods & Services Tax (GST)

Status From To
Registered Thu, 12th Apr 2012 current

Advertisements

Company Patents

Patent Application Number: 2014206143

General information:

Application date: Wed, 23rd Jul 2014
Patent status: Sealed

What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.

Patent type: STANDARD
Primary IPC mark: A61K 33/18
Accepted claims count: 24

International Patent Classification:

IPC Mark: A61P 11/00
Version date of the IPC Classification record: Sun, 1st Jan 2006
Section code: A - human necessities
Class code: 61 - medical or veterinary science; hygiene
Subclass code: P - specific therapeutic activity of chemical compounds or medicinal preparations
Main group code: 11 - drugs for disorders of the respiratory system
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: Thu, 24th Jul 2014
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request filing date: Wed, 23rd Jul 2014
Requested examination type: Request Full Examination
First report issue date: Thu, 28th Aug 2014
Examination section: B3 Chemistry-Biology
Expiry date: Sun, 23rd Jul 2034
Earliest priority date: Wed, 23rd Jul 2014
Acceptance Notice date: Thu, 23rd Oct 2014
Sealing date: Thu, 5th Feb 2015
Effective patent date: Wed, 23rd Jul 2014
Patent in force to: Mon, 23rd Jul 2018

Find company

VIC 3000 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.